Skip to Content

Tag: Monoclonal antibody therapy


Greg Lopresti

Specialty Providers

COVID infusion therapy shifts to the home

October 29, 2021Theresa Flaherty, Managing Editor

YARMOUTH, Maine – The Delta variant of COVID-19 has accelerated demand for monoclonal antibody therapy provided in the home, say home infusion providers, who are stepping up to meet that demand.  “Hospitals don’t have the bandwidth and they don’t want the patients in their settings,” said Greg LoPresti, CEO of Upstate HomeCare in Syracuse, N.Y. “Their intake process takes a long time compared to us. We’ve taken a lot of the caseloads off hospitals.”  In...

COVID-19, Home Infusion Therapy, Monoclonal antibody therapy, Upstate HomeCare


Read Full Articlered right arrow icon

Also Noted

Soleo Health tapped by health system to provide mAb therapy at home

September 21, 2021HME News Staff

FRISCO, Texas – Soleo Health has been selected by Houston Methodist to provide monoclonal antibody therapy (mAb) to COVID-19 patients in their homes. The hospital system is among the nation’s largest providers of mAb therapy and has a partnership with the U.S. Department of Human Services, supported by KPMG LLP, to expand access to the treatment to underserved and disadvantaged patients in the greater Houston area. “By teaming up with Houston Methodist to help patients receive therapy...

COVID-19, Monoclonal antibody therapy, Soleo Health


Read Full Articlered right arrow icon

Also Noted

Upstate joins NHIA in COVID treatment program

June 2, 2021HME News Staff

SYRACUSE, N.Y. – Upstate HomeCare has partnered with the National Home Infusion Therapy Association to offer monoclonal antibody therapies to patients with mild and moderate COVID-19. The NHIA COVID-19 Home Infusion Therapy (C-HIT) Program hosts an online listing of home infusion providers that have agreed to provide these therapies to eligible individuals in their communities. “Upstate HomeCare is proud to be part of the U.S. health care response to the pandemic in our community,”...

Home Infusion Therapy, Monoclonal antibody therapy, Upstate HomeCare


Read Full Articlered right arrow icon

Also Noted

NHIA urges commercial payers to cover COVID-19 treatment 

April 7, 2021HME News Staff

ALEXANDRIA, Va. – The National Home Infusion Association is urging commercial insurance plans to implement coverage policies for COVID-19 monoclonal antibody therapy used in the home. The association also says CMS’s current administration fee of approximately $310 is insufficient to cover the costs. In a study conducted in February, NHIA determined the cost of providing the therapy is between $584 and $1,746. NHIA encourages payers to work with the home...

Coronavirus Outbreak, Monoclonal antibody therapy, National Home Infusion Association


Read Full Articlered right arrow icon